Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO for Prevention of Thrombocytopenia in NSCLC
NCT01319669Phase 3Terminated
- Sponsor
- Chinese Society of Lung Cancer
- Start
- Feb 2011
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in Thrombocytopenia, sponsored by Chinese Society of Lung Cancer. Started Feb 2011; status: terminated.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01319669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01319669.